{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:10:31Z","timestamp":1789787431465,"version":"4.0.1"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.msard.2025.106568","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:36:45Z","timestamp":1749209805000},"page":"106568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Family planning in neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9925-8367","authenticated-orcid":false,"given":"Nevin","family":"Shalaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106568_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib173","unstructured":"Alexion Global Medical Information. Last Updated October 2024."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"3_suppl","key":"10.1016\/j.msard.2025.106568_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/0961203305LU2109OA","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871524916666160229115047","article-title":"Neuromyelitis optica (NMO IgG+) and genetic susceptibility, potential ethnic influences","volume":"18","author":"Alonso","year":"2018","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.msard.2025.106568_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.05.018","article-title":"The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio De Janeiro","volume":"310","author":"Alvarenga","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.msard.2025.106568_bib0009","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ajmg.a.32685","article-title":"Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature","volume":"149A","author":"Anderka","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.msard.2025.106568_bib0010","first-page":"471","article-title":"Placental transfer and metabolism of betamethasone in human pregnancy","volume":"49","author":"Anderson","year":"1977","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.msard.2025.106568_bib0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MJT.0b013e3182491e02","article-title":"Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring","volume":"21","author":"Bay Bjorn","year":"2014","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.msard.2025.106568_bib0012","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","article-title":"Steroid-hormone receptors\u2013many actors in search of a plot","volume":"83","author":"Beato","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.msard.2025.106568_bib0014","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bcpt.12367","article-title":"Use of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriage","volume":"116","author":"Bj\u00f8rn","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.msard.2025.106568_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","article-title":"Neuromyelitis optica and pregnancy","volume":"78","author":"Bourre","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0016","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1212\/NXI.0000000000000339","article-title":"Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study","volume":"4","author":"Bove","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106568_bib0018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.hlc.2020.10.007","article-title":"Pregnancy following heart transplantation: a single centre case series and review of the literature","volume":"30","author":"Boyle","year":"2021","journal-title":"Hear Lung Circ."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/21556660.2020.1721507","article-title":"Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations","volume":"9","author":"Caniba\u00f1o","year":"2020","journal-title":"J. Drug Assess."},{"key":"10.1016\/j.msard.2025.106568_bib0021","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.msard.2025.106568_bib0022","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.msard.2025.106568_bib0023","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.msard.2025.106568_bib0024","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1212\/NXI.0000000000000723","article-title":"Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder","volume":"7","author":"Ciplea","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"15","key":"10.1016\/j.msard.2025.106568_bib0025","doi-asserted-by":"crossref","first-page":"e2006","DOI":"10.1212\/WNL.0000000000011744","article-title":"Pregnancy in patients with AQP4-Ab, MOG-Ab, or double-negative neuromyelitis optica disorder","volume":"96","author":"Collongues","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106568_bib0026","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","article-title":"Breastfeeding after transplantation","volume":"28","author":"Constantinescu","year":"2014","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.msard.2025.106568_bib0027","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.00428","article-title":"Changes in human milk immunoglobulin profile during prolonged lactation","volume":"8","author":"Czosnykowska-\u0141ukacka","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.msard.2025.106568_bib0039","article-title":"Pregnancy and neuromyelitis optica spectrum disorder - reciprocal effects and practical recommendations: a systematic review","volume":"11","author":"D\u2019Souza","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0029","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.msard.2025.106568_bib0030","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1212\/NXI.0000000000000288","article-title":"Immunology of neuromyelitis optica during pregnancy","volume":"3","author":"Davoudi","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.msard.2025.106568_bib0032","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","article-title":"Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites","volume":"101","author":"de Boer","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106568_bib0033","doi-asserted-by":"crossref","first-page":"13504","DOI":"10.1073\/pnas.94.25.13504","article-title":"Glucocorticoidmediated repression of nuclear factor-kappa B-dependent transcription involves direct interference with transactivation","volume":"94","author":"De Bosscher","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0031","first-page":"99","article-title":"Age and fertility: a study on patient awareness","volume":"20","author":"Deatsman","year":"2016","journal-title":"JBRA Assist. Reprod."},{"key":"10.1016\/j.msard.2025.106568_bib0034","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.msard.2018.08.015","article-title":"Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica","volume":"25","author":"Delgado-Garc\u00eda","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12884-021-04158-w","article-title":"Prediction of miscarriage in first trimester by serum estradiol, progesterone and beta-human chorionic gonadotropin within 9 weeks of gestation","volume":"22","author":"Deng","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0036","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10408444.2011.653487","article-title":"The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy","volume":"42","author":"DeSesso","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0037","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/tera.1420490202","article-title":"Methotrexate exposure prior to and during pregnancy","volume":"49","author":"Donnenfeld","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.msard.2025.106568_bib0038","unstructured":"Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): national institute of child health and human development; 2006-. Methotrexate. [Updated 2023 Dec 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501341\/."},{"key":"10.1016\/j.msard.2025.106568_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.msard.2025.106568_bib0041","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/AOG.0000000000001936","article-title":"Risk of adverse pregnancy outcome after paternal exposure to methotrexate within 90 days before pregnancy","volume":"129","author":"Eck","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.msard.2025.106568_bib0043","unstructured":"Enspryng Summary of Product Characteristics. 2025 https:\/\/ec.europa.eu\/health\/documents\/community-register\/2021\/20210624151887\/anx_151887_en.pdf."},{"issue":"92","key":"10.1016\/j.msard.2025.106568_bib0044","article-title":"The efficacy and tolerability of azathioprine for patients with neuromyelitis optica spectrum disorder: a systematic review (P1.2-005)","author":"Espiritu","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106568_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.09.032","article-title":"Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis","volume":"313","author":"Feng","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106568_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0047","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00415-013-7031-y","article-title":"Neuromyelitis optica and pregnancy","volume":"260","author":"Fragoso","year":"2013","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106568_bib0048","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s40265-020-01370-4","article-title":"Inebilizumab: first approval","volume":"80","author":"Frampton","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2025.106568_bib0049","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cca.2019.12.013","article-title":"Changes of serum interleukin-6 in healthy pregnant women and establishment of relevant reference intervals","volume":"502","author":"Fu","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.msard.2025.106568_bib0050","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106568_bib167","first-page":"1","article-title":"Pregnancy characteristics in Egyptian female patients with NMOSD. Multiple Sclerosis Journal\u2014Experimental","author":"Gad","year":"2024","journal-title":"Translational and Clinical July\u2013September"},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0052","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/CPJ.0000000000001147","article-title":"Use of B-cell-depleting therapy in women of childbearing potential with multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"12","author":"Galati","year":"2022","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2025.106568_bib0053","unstructured":"Gardiner S. Drug safety in lactation. New Zealand medicines and medical devices safety authority. May 2001."},{"key":"10.1016\/j.msard.2025.106568_bib0054","unstructured":"Genentech. Rituxan (rituximab) [package insert]. 2021. accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/103705s5311lbl.pdf."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0974-1208.74152","article-title":"Fertility and age","volume":"3","author":"George","year":"2010","journal-title":"J. Hum. Reprod. Sci."},{"key":"10.1016\/j.msard.2025.106568_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.737673","article-title":"A comprehensive review on the role of genetic factors in neuromyelitis optica spectrum disorder","volume":"12","author":"Ghafouri-Fard","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2025.106568_bib0057","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2025.106568_bib0058","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobilogy"},{"key":"10.1016\/j.msard.2025.106568_bib0059","doi-asserted-by":"crossref","first-page":"111","DOI":"10.61796\/jmgcb.v1i2.373","article-title":"Navigating the immune response landscape of hepatitis B and Hepatitis C Virus Infections","volume":"1","author":"Hammood","year":"2024","journal-title":"J. Med. Genet. Clin. Biol."},{"issue":"10","key":"10.1016\/j.msard.2025.106568_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hern\u00e1ndez-D\u00edaz","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.msard.2025.106568_bib0061","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1182\/blood-2024-209857","article-title":"Ravulizumab in pregnant women with paroxysmal nocturnal hemoglobinuria (PNH) - favourable experience from a retrospective case series","volume":"144","author":"Hoechsmann","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0063","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158A","author":"Hoeltzenbein","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.msard.2025.106568_bib0062","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2016.05.004","article-title":"Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data","volume":"46","author":"Hoeltzenbein","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.msard.2025.106568_bib0064","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1007\/s00415-020-10235-5","article-title":"Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder","volume":"268","author":"Holmoy","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0065","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.4049\/jimmunol.178.8.5357","article-title":"Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies","volume":"178","author":"Hsu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib0066","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jns.2016.11.054","article-title":"Pregnancy in neuromyelitis optica spectrum disorder: a multicenter study from South China","volume":"372","author":"Huang","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2025.106568_bib0067","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415605486","article-title":"Expression of the astrocyte water channel aquaporin-4 in the mouse brain","volume":"7","author":"Hubbard","year":"2015","journal-title":"ASN Neuro"},{"key":"10.1016\/j.msard.2025.106568_bib0068","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.msard.2025.106568_bib0069","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(90)90395-U","article-title":"Antitumor promotion and antiinfl ammation: down-modulation of Ap-1 (Fos\/Jun) activity by glucocorticoid hormone","volume":"62","author":"Jonat","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.msard.2025.106568_bib0070","article-title":"Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach","author":"Joyce","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.msard.2025.106568_bib0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","volume":"271","author":"K\u00fcmpfel","year":"2024","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0071","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ajg.2008.71","article-title":"Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy","volume":"104","author":"Kane","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106568_bib0072","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/15321819.2022.2164507","article-title":"The predictive role of NF-\u03baB-mediated pro-inflammatory cytokine expression levels in hepatitis B vaccine response","volume":"44","author":"Karabay","year":"2023","journal-title":"J. Immunoass. Immunochem."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0074","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12016-009-8188-0","article-title":"The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management","volume":"40","author":"Karpuzoglu","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib0073","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.molimm.2006.08.005","article-title":"IFNgamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12","volume":"44","author":"Karpuzoglu","year":"2007","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2025.106568_bib0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2025.106568_bib0076","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/WNL.0b013e318250d812","article-title":"Influence of pregnancy on neuromyelitis optica spectrum disorder","volume":"78","author":"Kim","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2025.106568_bib0077","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.msard.2012.06.002","article-title":"Treatment of neuromyelitis optica: review and recommendations","volume":"1","author":"Kimbrough","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106568_bib0078","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1212\/WNL.0000000000004681","article-title":"High risk of postpartum relapses in neuromyelitis optica spectrum disorder","volume":"89","author":"Klawiter","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106568_bib0079","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106568_bib0081","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1701-2163(16)34622-9","article-title":"Prenatal exposure to mycophenolate mofetil: an updated estimate","volume":"32","author":"Klieger-Grossmann","year":"2010","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0084","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1212\/NXI.0000000000000637","article-title":"Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions","volume":"7","author":"Krysko","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106568_bib0083","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11940-021-00666-4","article-title":"Treatment of women with multiple sclerosis planning pregnancy","volume":"23","author":"Krysko","year":"2021","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0082","article-title":"Family planning considerations in people with multiple sclerosis","volume":"22","author":"Krysko","year":"2022","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0086","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000913","article-title":"Anti-CD20therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany","volume":"8","author":"Kumpfel","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0087","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/CON.0000000000000745","article-title":"Pregnancy and family planning in multiple sclerosis","volume":"25","author":"Langer-Gould","year":"2019","journal-title":"Continuum"},{"key":"10.1016\/j.msard.2025.106568_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104760","article-title":"A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)","volume":"75","author":"Leite","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0089","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40262-021-01092-0","article-title":"Pharmacokinetic\/pharmacodynamic considerations of alternate dosing strategies of Tocilizumab in COVID-19","volume":"61","author":"Leung","year":"2022","journal-title":"Clin. Pharmacokinet."},{"issue":"Pt 7","key":"10.1016\/j.msard.2025.106568_bib0090","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0091","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevImmunol.v29.i3.50","article-title":"Traditional concepts and future avenues of glucocorticoid action in experimental autoimmune encephalomyelitis and multiple sclerosis therapy","volume":"29","author":"Luhder","year":"2009","journal-title":"Crit. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0092","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12902-020-00569-6","article-title":"Role of anti-Mullerian hormone and testosterone in follicular growth: a cross-sectional study","volume":"20","author":"Lv","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.msard.2025.106568_bib0093","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-021-02266-0","article-title":"Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder","volume":"18","author":"Ma","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"16","key":"10.1016\/j.msard.2025.106568_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168946","article-title":"Th17- related cytokines as potential discriminatory markers between neuromyelitis optica (Devic\u2019s disease) and multiple sclerosis-a review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106568_bib0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1937-6448(08)02002-9","article-title":"Chapter 2: hypothalamic neural systems controlling the female reproductive life cycle gonadotropin-releasing hormone, glutamate, and GABA","volume":"274","author":"Maffucci","year":"2009","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.msard.2025.106568_bib0097","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am. J. Reprod. Imunol."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0098","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41582-020-0313-y","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations","volume":"16","author":"Mao-Draayer","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106568_bib0099","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/acn3.51147","article-title":"Genetic factors for susceptibility to and manifestations of neuromyelitis optica","volume":"7","author":"Matsushita","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0100","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0101","unstructured":"METHOTREXATE tablets, For oral use. Revised August 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/040054s015.s016,s017.pdf."},{"key":"10.1016\/j.msard.2025.106568_bib0102","unstructured":"Morgan M., Campos A., Murphy A., et al. Contrast media and breastfeeding. Reference article, Radiopaedia.org. last revised May 2024 (Accessed on 23 Aug 2024) 10.53347\/rID-33488."},{"issue":"4","key":"10.1016\/j.msard.2025.106568_bib0013","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9378(16)33697-3","article-title":"Conversion of maternal cortisol to cortisone during placental transfer to the human fetus","volume":"118","author":"Beverley","year":"1974","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.msard.2025.106568_bib0001","unstructured":"Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients. https:\/\/www.gov.uk\/. Drug Safety Update, Feb 6, 2018)."},{"key":"10.1016\/j.msard.2025.106568_bib0103","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/14397595.2016.1147405","article-title":"Pregnancy outcomes after exposure to tocilizumab: a retrospective analysis of 61 patients in Japan","volume":"26","author":"Nakajima","year":"2016","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0104","article-title":"Successful Childbirth during satralizumab treatment in neuromyelitis optica spectrum disorder","volume":"16","author":"Nakashima","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.msard.2025.106568_bib0105","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1152\/physrev.2001.81.4.1535","article-title":"Mechanisms of estrogen action","volume":"81","author":"Nilsson","year":"2001","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0106","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/cen3.12724","article-title":"Monoclonal antibody treatment during pregnancy and lactation in women with multiple sclerosis or neuromyelitis optica spectrum disorder","volume":"13","author":"Nohara","year":"2022","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106568_bib168","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2036.2003.01537.x","article-title":"Azathioprine, mercaptopurine and birth outcome: a population-based cohort study","volume":"17","author":"Norgard","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","article-title":"Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"86","author":"Nour","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106568_bib0108","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0092-8674(00)80726-6","article-title":"A unified nomenclature system for the nuclear receptor superfamily","volume":"97","year":"1999","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1212\/CPJ.0000000000000586","article-title":"Neuromyelitis optica spectrum disorder with area postrema syndrome","volume":"9","author":"Okada","year":"2019","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2025.106568_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib0111","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molimm.2012.06.013","article-title":"Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity","volume":"53","author":"Panchanathan","year":"2013","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.msard.2025.106568_bib0112","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106568_bib0113","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106568_bib0114","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.msard.2025.106568_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20080521","article-title":"Estrogen directly activates AID transcription and function","volume":"206","author":"Pauklin","year":"2009","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0116","article-title":"Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series","volume":"5","author":"Perrotta","year":"2021","journal-title":"Rheumatol. Adv. Pract."},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106568_bib0117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","article-title":"Estrogen receptor profiles in human peripheral blood lymphocytes","volume":"132","author":"Pierdominici","year":"2010","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.7.3.219","article-title":"The safety of mycophenolate mofetil in pregnancy","volume":"7","author":"Pisoni","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.msard.2025.106568_bib0119","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib0121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1096\/fj.04-1901hyp","article-title":"Pregnancy-induced up-regulation of aquaporin-4 protein in brain and its role in eclampsia","volume":"19","author":"Quick","year":"2005","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0123","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp-2022-329545","article-title":"Safety of breast feeding during rituximab treatment in multiple sclerosis","volume":"94","author":"R\u00f8d","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.msard.2025.106568_bib0122","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/1352458513498125","article-title":"Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low dose rituximab postpartum","volume":"19","author":"Ringelstein","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106568_bib0124","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","article-title":"Neuromyelitis optica IgG causes placental inflammation and fetal death","volume":"191","author":"Saadoun","year":"2013","journal-title":"J. Immunol."},{"issue":"88","key":"10.1016\/j.msard.2025.106568_bib0125","article-title":"Placental transmission of AQP4-IgG to neonate from mothers with neuromyelitis optica spectrum disorder (NMOSD) (S20.006)","author":"Sagen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106568_bib0127","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.msard.2025.106568_bib0126","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/rheumatology\/key091","article-title":"Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study","volume":"57","author":"Saito","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.msard.2025.106568_bib0128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/ror.0.0040081","article-title":"Dynamics of immunoglobulins at the feto\u2013maternal interface","volume":"4","author":"Saji","year":"1999","journal-title":"Rev. Reprod."},{"issue":"4","key":"10.1016\/j.msard.2025.106568_bib0129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.vaccine.2007.11.049","article-title":"The role of complement in the success of vaccination with conjugated vs. unconjugated polysaccharide antigen","volume":"26","author":"Salehen","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.msard.2025.106568_bib0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-018-0517-z","article-title":"Eculizumab in pregnancy: a narrative overview","volume":"32","author":"Sarno","year":"2019","journal-title":"J. Nephrol."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0132","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor \u03b1 signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.msard.2025.106568_bib0133","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/1352458515583376","article-title":"Pregnancy related relapse risk factors in women with anti- AQP4 antibody positivity and neuromyelitis optica spectrum disorder","volume":"22","author":"Shimizu","year":"2016","journal-title":"Mult. Scler."},{"issue":"14","key":"10.1016\/j.msard.2025.106568_bib0134","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1177\/1352458517740215","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: interactions and management","volume":"23","author":"Shosha","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106568_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-012-8293-7","article-title":"Activation and regulation of interferon-\u03b2 in immune responses","volume":"53","author":"Sin","year":"2012","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103499","article-title":"Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: a comprehensive review","volume":"23","author":"Siriratnam","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.msard.2025.106568_bib0137","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.annepidem.2014.06.005","article-title":"First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway","volume":"24","author":"Skuladottir","year":"2014","journal-title":"Ann. Epidemiol."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0138","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.15790","article-title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis","volume":"185","author":"Socie","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.msard.2025.106568_bib0139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1753495X19841799","article-title":"The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy","volume":"13","author":"Soh","year":"2019","journal-title":"Obstet. Med."},{"issue":"10","key":"10.1016\/j.msard.2025.106568_bib0140","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-023-01036-1","article-title":"Assisted reproductive technology and disease management in infertile women with multiple sclerosis","volume":"37","author":"Sparaco","year":"2023","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0141","first-page":"119","article-title":"Medications in the breast-feeding mother","volume":"64","author":"Spencer","year":"2001","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.msard.2025.106568_bib172","unstructured":"Soliris summary of product characteristics."},{"issue":"5","key":"10.1016\/j.msard.2025.106568_bib0142","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.msard.2025.106568_bib0143","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2006.12.040","article-title":"Aquaporin 4 regulates the effects of ovarian hormones on monoamine neurotransmission","volume":"353","author":"Sun","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.msard.2025.106568_bib0144","article-title":"Neuromyelitis optica spectrum disorder relapse during the third trimester of pregnancy","volume":"2","author":"Tallavajhala","year":"2022","journal-title":"Neuroimmunol. Rep."},{"key":"10.1016\/j.msard.2025.106568_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101977","article-title":"Neuromyelitis optica spectrum disorder with severe orthostatic hypotension due to hypothalamic lesions","volume":"40","author":"Tanaka","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106568_bib0146","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fneur.2018.00446","article-title":"Ovarian reserve in women with neuromyelitis optica spectrum disorder","volume":"9","author":"Thone","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106568_bib0147","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.msard.2018.07.006","article-title":"Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"25","author":"Tong","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106568_bib0148","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.23741","article-title":"Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody","volume":"73","author":"Tradtrantip","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106568_bib0150","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/rheumatology\/keaa064","article-title":"Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies","volume":"59","author":"Tsao","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.msard.2025.106568_bib169","unstructured":"Ultomiris summary of product characteristics."},{"key":"10.1016\/j.msard.2025.106568_bib0151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2019.05.066","article-title":"Fetal methotrexate syndrome: a systematic review of case reports","volume":"87","author":"Verberne","year":"2019","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.msard.2025.106568_bib0152","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0153","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/13524585221130934","article-title":"Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society","volume":"29","author":"Vukusic","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/13524585221130934","article-title":"Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French multiple sclerosis society","volume":"29","author":"Vukusic","year":"2023","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2025.106568_bib0156","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jnnp-2020-323982","article-title":"Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors","volume":"92","author":"Wang","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106568_bib0157","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103181","article-title":"Efficacy of mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorders: an update systematic review and meta -analysis","volume":"55","author":"Wang","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2025.106568_bib0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25438","article-title":"Analysis of pregnancy-related attacks in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.msard.2025.106568_bib0158","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104627","article-title":"Familial neuromyelitis optica spectrum disorders: case series and systematic review","volume":"73","author":"Wannaphut","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2025.106568_bib0159","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/1352458507077189","article-title":"Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis","volume":"13","author":"Watanabe","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106568_bib0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.reprotox.2016.01.002","article-title":"Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center","volume":"60","author":"Weber-Schoendorfer","year":"2016","journal-title":"Reprod. Toxicol."},{"issue":"7","key":"10.1016\/j.msard.2025.106568_bib0161","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40262-019-00742-8","article-title":"Pharmacology, pharmacokinetics and pharmacodynamics of eculizumab, and possibilities for an individualized approach to eculizumab","volume":"58","author":"Wijnsma","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.msard.2025.106568_bib0162","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1322412","article-title":"Neuromyelitis optica spectrum disorder safely and successfully treated with satralizumab during pregnancy and breastfeeding: a case report","volume":"14","author":"Yoshida","year":"2023","journal-title":"Front. Neurol."},{"issue":"3 Pt 2","key":"10.1016\/j.msard.2025.106568_bib0163","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2023.05.005","article-title":"Methotrexate use among men-association with fertility and the perinatal health of their children: a Swedish nationwide register study","volume":"120","author":"Zar\u00e9n","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.msard.2025.106568_bib0164","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s13760-016-0654-x","article-title":"Neuromyelitis optica and pregnancy","volume":"116","author":"Zare-Shahabadi","year":"2016","journal-title":"Acta Neurol. Belg."},{"issue":"7","key":"10.1016\/j.msard.2025.106568_bib0165","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/ene.14771","article-title":"Whole-exome sequencing reveals the major genetic factors contributing to neuromyelitis optica spectrum disorder in Chinese patients with aquaporin 4-IgG seropositivity","volume":"28","author":"Zhong","year":"2021","journal-title":"Eur. J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825003104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:40:45Z","timestamp":1755650445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":164,"alternative-id":["S2211034825003104"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106568","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Family planning in neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106568"}}